M Warm
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 3
- PARP inhibition in cancer therapy 2
-
- Breast Cancer Treatment Studies 9
- Co-authors
- W. Eiermann (2 shared papers)Kay Friedrichs (2 shared papers)Thorsten Kühn (2 shared papers)Sherko Kümmel (3 shared papers)Jens‐Uwe Blohmer (3 shared papers)Isabell Witzel (1 shared paper)Christian Jackisch (1 shared paper)Andreas Schneeweiß (1 shared paper)
- Journals
- Cancer Research (5 papers)Journal of Clinical Oncology (4 papers)Archives of Gynecology and Obstetrics (2 papers)Annals of Oncology (2 papers)International Journal of Gynecological Cancer (1 paper)
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
M Warm
22 papers receiving 232 citations
Peers
Comparison fields: 5 of 44
- Cancer Research 123
- Reproductive Medicine 47
- Oncology 106
- Obstetrics and Gynecology 23
- Hematology 19
Countries citing papers authored by M Warm
This map shows the geographic impact of M Warm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Warm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Warm more than expected).
Fields of papers citing papers by M Warm
This network shows the impact of papers produced by M Warm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Warm. The network helps show where M Warm may publish in the future.
Co-authors
The 25 scholars most cited alongside M Warm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 116 | |
| 2 | Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group. | 1997 | 49 |
| 3 | 2013 | 15 | |
| 4 | 2010 | 9 | |
| 5 | 2020 | 8 | |
| 6 | 2020 | 6 | |
| 7 | 2022 | 6 | |
| 8 | 2003 | 5 | |
| 9 | 2019 | 4 | |
| 10 | 2009 | 4 | |
| 11 | 2005 | 3 | |
| 12 | 2012 | 2 | |
| 13 | 2012 | 2 | |
| 14 | 2009 | 2 | |
| 15 | 2008 | 1 | |
| 16 | 2011 | 1 | |
| 17 | 2009 | 1 | |
| 18 | 2010 | 1 | |
| 19 | 2010 | 1 | |
| 20 | 2010 | 1 |
About M Warm
M Warm is a scholar working on Oncology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Genetics, having authored 23 papers that have together received 239 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (7 papers), Advanced Breast Cancer Therapies (5 papers), Reconstructive Surgery and Microvascular Techniques (4 papers), HER2/EGFR in Cancer Research (3 papers), Breast Implant and Reconstruction (3 papers), BRCA gene mutations in cancer (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Cancer Research (123 citations), Reproductive Medicine (47 citations), Oncology (106 citations), Obstetrics and Gynecology (23 citations) and Hematology (19 citations). M Warm has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include W. Eiermann, Kay Friedrichs, Thorsten Kühn, Sherko Kümmel, Jens‐Uwe Blohmer, Isabell Witzel, Christian Jackisch, Andreas Schneeweiß, Holm Eggemann and Mahdi Rezai. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Archives of Gynecology and Obstetrics, Annals of Oncology and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.